BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

Menten AI

Menten is a biotech startup developing a software platform for protein design empowered by machine learning and quantum computing. Menten’s quantum approach aims to overcome the scalability challenges that limit classical methods in computational protein design to significantly improve accuracy and reduce development time. Menten’s goal is to create the computational tools required to deliver on the promise of protein-based medicine and biocatalysis.

quantum computing protein design

Interviews


Posts Mentioning This Company

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

  
(Updated: 24.02.2024) Molecular mechanics (MM) is a traditional computational approach when it comes to modeling in synthetic organic chemistry, medicinal chemistry, and versatile aspects of drug design. However, MM methods have significant limitations, for example, when used to study electron-based properties within the drug-receptor microenvironment. Quantum mechanical (QM) methods allow …